Optimizing Treatment With Thioguanine Derivatives in Inflammatory Bowel Disease

Best Practice and Research in Clinical Gastroenterology - United Kingdom
doi 10.1053/bega.2002.0346
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Thioguanine in Inflammatory Bowel Disease: Long-Term Efficacy and Safety

United European Gastroenterology Journal
OncologyGastroenterology
2016English

Utilisation of Erythrocyte 6-Thioguanine Metabolite Levels to Optimise Azathioprine Therapy in Patients With Inflammatory Bowel Disease

Gut
Gastroenterology
2001English

Treatment Patterns and Sequencing in Patients With Inflammatory Bowel Disease

Clinical Therapeutics
Pharmacology
2018English

Methotrexate in the Treatment of Inflammatory Bowel Disease

Przeglad Gastroenterologiczny
Gastroenterology
2011English

Methotrexate Treatment for a Dog With an Inflammatory Bowel Disease

Journal of the Japan Veterinary Medical Association
2007English

Inflammatory Bowel Disease and Current Treatment Options in Dogs

American Journal of Animal and Veterinary Sciences
Animal ScienceZoologyVeterinary
2017English

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-Life Intercept Cohorts

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2017English

Inflammatory Bowel Disease

Annual Review of Immunology
AllergyImmunology
2010English

Inflammatory Bowel Disease

American Journal of Gastroenterology
HepatologyGastroenterology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy